C. Charpin

发表

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.

Daniel Birnbaum, Dominique Maraninchi, Pascal Finetti, 2006, Cancer research.

High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes

Daniel Birnbaum, Anthony Ferrari, Pascal Finetti, 2011, PloS one.

Quantitative immunocytochemical assays on frozen sections of p53: correlation to the follow-up of patients with breast carcinomas.

P. Bonnier, L. Andrac, C. Charpin, 1996, American journal of clinical pathology.

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.

P. Bonnier, L. Andrac, C. Charpin, 2004, International journal of oncology.

Direct colposcopic vision used with the LLETZ procedure for optimal treatment of CIN: results of joint cohort studies

A. Agostini, W. Prendiville, G. Houvenaeghel, 2013, Archives of Gynecology and Obstetrics.

Prognostic factors in ductal carcinoma in situ of the breast: results of a retrospective study of 575 cases. The Association for Research in Oncologic Gynecology.

P. Bonnier, G. Body, C. Charpin, 1999, European journal of obstetrics, gynecology, and reproductive biology.

Impact of menopausal hormone‐replacement therapy on clinical and laboratory characteristics of breast cancer

A. Sasco, S. Romain, P. Bonnier, 1998, International journal of cancer.

X-raying of sliced surgical specimens during surgery: an improvement of the histological diagnosis of impalpable breast lesions with microcalfications.

P. Bonnier, L. Andrac, C. Charpin, 1992, Anticancer research.

[Reproducibility of histoprognostic grades of invasive breast cancer].

J. Jacquemier, C. Charpin, 1998, Annales de pathologie.

Mutations at BRCA1: the medullary breast carcinoma revisited.

D. Birnbaum, J. Peyrat, D. Stoppa-Lyonnet, 1998, Cancer research.

Influence of pregnancy on the outcome of breast cancer: A case‐control study

J. Julien, S. Romain, P. Bonnier, 1997, International journal of cancer.

Endometrial Response to Sexual Steroids as Assessed by Prostaglandin F2α Output in Explant Culture and Hormone Receptor Expression

C. Charpin, L. Boubli, C. Allasia, 2000, Gynecologic and Obstetric Investigation.

Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR.

P. Bonnier, L. Andrac, C. Charpin, 1992, Anticancer research.

Characterization and Distribution in Human Tissues of a Glycoproteic Antigen Defined by Monoclonal Antibody 1BE12Raised against the Human Breast Cancer Cell Line T47D1

E. Osinaga, F. Calvo, G. Pancino, 2006 .

ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays.

L. Andrac, C. Charpin, S. Garcia, 1998, International journal of oncology.

Immunohistochemical study of pheochromocytomas. An investigation of methionine-enkephalin, vasoactive intestinal peptide, somatostatin, corticotropin, beta-endorphin, and calcitonin in 16 tumors.

Jean, P. Giraud, G. Monges, 1984, The American journal of pathology.

Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma tissue sections.

L. Andrac, C. Charpin, B. Devictor, 1988, Cancer research.

Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.

E. Osinaga, G. Pancino, C. Charpin, 1991, British Journal of Cancer.

[Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].

C. Oliver, C. Charpin, M. Cannoni, 1984, Annales de pathologie.

Laminin biosynthesis in the extracellular matrix-producing cell line PFHR9 studied with monoclonal and polyclonal antibodies.

J. Lissitzky, C. Bignon, C. Charpin, 1988, The Biochemical journal.

Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.

E. Osinaga, F. Calvo, G. Pancino, 1990, Cancer research.

A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.

F. Calvo, G. Pancino, C. Charpin, 1987, Cancer research.

A Novel Monoclonal Antibody ( 7 B 10 ) with Differential Reactivity between Human Mammary Carcinoma and Normal Breast 1

F. Calvo, G. Pancino, C. Charpin, 1987 .

Mutations at BRCAJ: The Medullary Breast Carcinoma Revisited1

D. Birnbaum, J. Peyrat, D. Stoppa-Lyonnet, 2015 .

Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: II--Morphometric assessment.

D. Charpin, D. Vervloet, C. Charpin, 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Fel d I allergen: skin and or saliva?

D. Charpin, D. Vervloet, C. Charpin, 1992, Annals of allergy.

Fel d I allergen distribution in cat fur and skin.

D. Charpin, D. Vervloet, C. Charpin, 1991, The Journal of allergy and clinical immunology.

CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up.

P. Bonnier, L. Andrac, C. Charpin, 1997, American journal of clinical pathology.

Purification andcharacterisation ofabreast-cancer-as sociated glycoprotein notexpressed innormal breast andidentified bymonoclonal antibody 83D4

C. Charpin, E. O. Pancinol, D. Mistrol, 1991 .

Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.

F. Bertucci, D. Birnbaum, P. Finetti, 2008, Cancer research.

Reappraisal of breast hamartomas. A morphological study of 41 cases.

P. Bonnier, L. Andrac, C. Charpin, 1994, Pathology, research and practice.

A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays

P. Bonnier, V. Secq, L. Andrac, 2009, International journal of cancer.

Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival.

P. Bonnier, L. Andrac, C. Charpin, 1998, American journal of clinical pathology.

Two monoclonal antibodies identify antigens preferentially expressed on normal human breast cells versus breast cancer cells.

P. de Cremoux, E. Osinaga, F. Calvo, 1991, Hybridoma.

Calcitonin, somatostatin and ACTH immunoreactive cells in a case of familial bilateral thyroid medullary carcinoma

J. Hassoun, M. Monier‐Faugere, L. Andrac, 1982, Cancer.

Inflammatory carcinoma of the breast.

S. Romain, P. Bonnier, C. Charpin, 1992, European journal of gynaecological oncology.

Expression of her-2/neu oncogene in breast-cancer - correlation of quantitative immunocytochemistry and prognostic factors.

P. Bonnier, L. Andrac, C. Charpin, 1992, International journal of oncology.

[Immunohistochemical study using monoclonal antibodies (H222 SP gamma) of estrogen receptors: correlation with biochemical analysis (by radioligand) of 115 breast carcinomas].

J. Jacquemier, C. Charpin, P. Martin, 1986, Bulletin du cancer.

Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.

J. Jacquemier, L. Andrac, C. Charpin, 1988, The American journal of pathology.

Cathepsin D immunocytochemical assays in breast carcinomas: Image analysis and correlation to prognostic factors

P. Bonnier, L. Andrac, C. Charpin, 1993, The Journal of pathology.

Estrogen response of MCF-7 cells grown on diverse substrates and in suspension culture: promotion of morphological heterogeneity, modulation of progestin receptor induction; cell-substrate interactions on collagen gels.

J. Jacquemier, C. Charpin, Y. Berthois, 1984, Journal of steroid biochemistry.

Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?

S. Romain, P. Bonnier, pierre-Marie Martin, 1995, International journal of cancer.

c-myc protein and Ki-67 antigen immunodetection in patients with uterine cervix neoplasia: correlation of microcytophotometric analysis and histological data.

P. Bonnier, L. Andrac, C. Charpin, 1993, Gynecologic oncology.

Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome

P. Bonnier, V. Secq, L. Andrac, 2009, British Journal of Cancer.

Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.

J. Jacquemier, C. Charpin, P. Martin, 1986, Cancer research.

Correlation of nucleolar organizer regions and nuclear morphometry assessed by automatic image analysis in breast cancer with aneuploidy, K167 immunostaining, histopathologic grade and lymph node involvement.

P. Bonnier, L. Andrac, C. Charpin, 1992, Pathology, research and practice.

CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients.

P. Bonnier, F. Duffaud, C. Charpin, 2003, American journal of clinical pathology.

Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.

V. Zurawski, R. Scully, A. Bhan, 1982 .

Laminin distribution in human decidua and immature placenta. An immunoelectron microscopic study (avidin-biotin-peroxidase complex method).

J. Lissitzky, C. Charpin, P. Martin, 1985, American journal of obstetrics and gynecology.

p53 quantitative immunocytochemical analysis in breast carcinomas.

L. Andrac, C. Charpin, C. Allasia, 1995, Human pathology.

Monoclonal antibody 83D4 immunoreactivity in human tissues: cellular distribution and microcytophotometric analysis of immunoprecipitates on tissue sections.

P. Bonnier, E. Osinaga, G. Pancino, 1992, Anticancer research.

Production of a monoclonal antibody as immunohistochemical marker on paraffin embedded tissues using a new immunization method.

E. Osinaga, G. Pancino, C. Charpin, 1990, Hybridoma.

How culture conditions modulate the morphofunctional differentiation of the human estradiol-sensitive mammary cell line (MCF-7).

S. Nandi, J. Jacquemier, C. Charpin, 1984, Journal of steroid biochemistry.

Correlation between laminin and Type IV collagen distribution in Breast Carcinomas, and Estrogen receptors expression, Lymph Node and Vascular involvement

L. Xerri, D. Figarella-Branger, P. Casanova, 1990, Medical oncology and tumor pharmacotherapy.

Immunohistochemical detection of laminin in 98 human breast carcinomas: a light and electron microscopic study.

J. Lissitzky, J. Jacquemier, C. Charpin, 1986, Human pathology.

Estrogen Receptor Immunocytochemical Assay (ER-ICA) and Laminin Detection in 115 Breast Carcinomas: A Light and Electron Microscopy Study with a Computerized (Samba 200) Quantitative Analysis on Tissue Sections

J. Jacquemier, C. Charpin, P. Martin, 1986 .

[Polycystic disease of the salivary glands: report of an attack of the submaxillary glands].

L. Andrac, C. Charpin, S. Garcia, 1998, Annales de Pathologie.

Herpes simplex virus antigen detection in human acute encephalitis:

J. Seigneurin, M. Raphael, C. Charpin, 2004, Acta Neuropathologica.

Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features

L Piana, S. Romain, P. Bonnier, 1995, International journal of cancer.

Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction

Y. Couté, Y. Vandenbrouck, E. Duchemin-Pelletier, 2013, Oncogene.

Overexpression of hypoxia‐inducible factor HIF‐1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients

P. Bonnier, Claude Allasia, Pascal Bonnier, 2005, International journal of cancer.

Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.

C. Charpin, L. Boubli, J. Dales, 2003, International journal of molecular medicine.

bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up.

P. Bonnier, L. Andrac, C. Charpin, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays.

D. Birnbaum, J. Iovanna, P. Bonnier, 2011, European journal of cancer.

Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.

L. Andrac, C. Charpin, C. Allasia, 1997, British Journal of Cancer.

Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.

P. Bonnier, L. Andrac, C. Charpin, 1997, Journal of clinical pathology.

Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype.

P. Bonnier, E. Charafe-Jauffret, J. Jacquemier, 2007, Human pathology.

Epidermal growth factor receptor in breast cancer: Correlation of quantitative immunocytochemical assays to prognostic factors

P. Bonnier, L. Andrac, C. Charpin, 2004, Breast Cancer Research and Treatment.

Tumor Neoangiogenesis by CD31 and CD105 Expression Evaluation in Breast Carcinoma Tissue Microarrays

P. Bonnier, L. Andrac, C. Charpin, 2004, Clinical Cancer Research.

Myopathy associated with desmin type intermediate filaments An immunoelectron microscopic study

J. Pouget, C. Charpin, J. Pellissier, 1989, Journal of the Neurological Sciences.

Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer

Christophe Picard, Nathalie Beaufils, C. Formisano-Tréziny, 2010, BMC medicine.

Localization of lactoferrin and nonspecific cross‐reacting antigen in human breast carcinomas. An immunohistochemical study using the Avidin—biotin—peroxidase complex method

J. Jacquemier, C. Charpin, M. Lavaut, 1985, Cancer.

Clinicopathologic growth factors in vestibular schwannomas: a morphological and immunohistochemical study of 69 tumours.

C. Charpin, C. Bouvier, L. Andrac‐Meyer, 2000, Acta oto-laryngologica.

Myoepithelial carcinoma of the breast: a clinicopathological and immunohistochemical study of 15 diagnostically challenging cases

N. Buza, F. Tavassoli, C. Charpin, 2010, Virchows Archiv.

Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.

P. Bonnier, Jean P Dales, Stephane Garcia, 2004, Human pathology.

CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.

L Piana, L. Andrac, C. Charpin, 1995, American journal of clinical pathology.

Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10‐year follow‐up by automated and quantitative immunocytochemical assays

P. Bonnier, L. Andrac, C. Charpin, 1998, The Journal of pathology.

Laminin immunodetection in tumorous and nontumorous disorders of human thyroid.

J. Lissitzky, C. Charpin, P. Martin, 1985, Bulletin du cancer.

Non palpable breast carcinomas. Histological and immunohistochemical studies of 160 cases.

L Piana, P. Bonnier, L. Andrac, 1993, Pathology, research and practice.

Immunohistochemical and immunoelectron-microscopic study of pituitary adenomas associated with Cushing's disease. A report of 13 cases.

C. Oliver, J. Hassoun, C. Charpin, 1982, The American journal of pathology.

VCAM (IGSF) adhesion molecule expression in breast carcinomas detected by automated and quantitative immunocytochemical assays.

L. Andrac, C. Charpin, C Charpin, 1998, Human pathology.

VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.

L. Andrac, C. Charpin, S. Garcia, 1998, British Journal of Cancer.

Immunodetection in fine‐needle aspirates and multiparametric (SAMBA) image analysis. Receptors (monoclonal antiestrogen and antiprogesterone) and growth fraction (monoclonal Ki67) evaluation in breast carcinomas

L. Xerri, Lucile Andrac, Colette Charpin, 1989, Cancer.

Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.

L. Andrac, C. Charpin, C Charpin, 1988, Cancer research.

Corticolipotropin immunoreactivity in silent chromophobe adenomas: a light and electron microscopic study.

J. Lissitzky, J. Hassoun, C. Charpin, 1982, Archives of pathology & laboratory medicine.

E‐cadherin quantititive immunocytochemical assays in breast carcinomas

C. Bouvier, L. Andrac, C. Charpin, 1997, The Journal of pathology.

c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.

P. Bonnier, L. Andrac, C. Charpin, 1997, British Journal of Cancer.

Monoclonal 3c6f9 distribution in human breast carcinomas: image cytometry of immunocytochemical assays

P. Bonnier, B. Barbeau, C. Charpin, 1991, Medical oncology and tumor pharmacotherapy.

[Retroperitoneal ectopic pregnancy: report of a case].

C. Charpin, J. Hardwigsen, S. Garcia, 1998, Annales de pathologie.

Uterine angiomyolipoma associated with pregnancy.

C. Charpin, P. Giacalone, F. Laffargue, 1993, Gynecologic oncology.

Immunocytochemical assays in human endometrial carcinomas: a multiparametric computerized analysis and comparison with nonmalignant changes.

L. Xerri, L. Andrac, C. Charpin, 1989, Gynecologic oncology.

Type IV collagen immunostaining and computerized image analysis (SAMBA) in breast and endometrial disorders

L. Xerri, L. Andrac, C. Charpin, 1989, Histopathology.

Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.

P. Bonnier, F. Duffaud, C. Charpin, 2003, International journal of oncology.

Kappa casein, lactalbumin and GCDFP 70 localization in human breast carcinomas: An immunohistochemical study using the avidin-biotin-peroxidase complex method

J. Jacquemier, C. Charpin, P. Martin, 1985, Medical oncology and tumor pharmacotherapy.

Validation of an immunohistochemical signature predictive of 8‐year outcome for patients with breast carcinoma

D. Birnbaum, J. Iovanna, P. Bonnier, 2012, International journal of cancer.

Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk.

D. Birnbaum, J. Iovanna, P. Bonnier, 2010, International journal of oncology.

Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis.

P. Bonnier, E. Charafe-Jauffret, J. Jacquemier, 2007, International journal of oncology.

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations

J. Iovanna, C. Charpin, L. Boubli, 2014, British Journal of Cancer.

Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.

P. Bonnier, Claude Allasia, Pascal Bonnier, 2005, International journal of oncology.

Carcinoembryonic Antigen (CEA) and Carbohydrate Determinant 19–9 (CA 19–9) Localization in 121 Primary and Metastatic Ovarian Tumors: An Immunohistochemical Study with the Use of Monoclonal Antibodies

V. Zurawski, R. Scully, A. Bhan, 1982, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].

P. Bonnier, F. Duffaud, L. Andrac, 2003, Annales de pathologie.

Mos oncogene expression in human ovarian tumors.

D. Birnbaum, L. Xerri, C. Charpin, 1991, Anticancer research.

Comparison of the prognostic significance of current and modified histological grades in breast carcinomas.

L. Andrac, C. Charpin, C. Allasia, 1995, Anticancer research.

Image cytometry of aneuploidy, growth fraction (MoAb Ki-67) and hormone receptors (ER, PR) immunocytochemical assays in breast carcinomas.

P. Bonnier, L. Andrac, C. Charpin, 1990, Analytical Cellular Pathology.

Effects of castration and testosterone on Fel d I production by sebaceous glands of male cats: II—morphometric assessment

D. Charpin, D. Vervloet, C. Charpin, 1994 .

Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.

C. Bouvier, L. Andrac, C. Charpin, 1997, Human pathology.

Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.

P. Vielh, F. Duffaud, L. Andrac, 1994, Journal of the National Cancer Institute.

Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas.

P. Bonnier, V. Secq, L. Andrac, 2009, International journal of oncology.

[Pelvic tumoral actinomycosis: a difficult diagnosis. Two case reports].

P. Bonnier, C. Charpin, L. Piana, 1999, Contraception, fertilite, sexualite.

Immunoexpression of E-cadherin and beta-catenin correlates to survival of patients with hepatocellular carcinomas.

Y. L. Le Treut, L. Andrac, C. Charpin, 1998, International journal of oncology.

[Effects of hormone replacement therapy for menopause on prognostic factors of breast cancer].

P. Bonnier, R. Sakr, C. Charpin, 2000, Gynecologie, obstetrique & fertilite.

[Immunohistochemical detection of estrogen receptors and image analysis (SAMBA 200) in breast carcinomas].

L. Andrac, C. Charpin, P. Martin, 1988, Annales de Pathologie.

Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas

C. Bouvier, L. Andrac, C. Charpin, 1997, International journal of cancer.